Megan leads the UK Government's Dementia Mission in the Office for Life Sciences, a joint unit of the Department for Science, Innovation and Technology and the Department of Health and Social Care. The Dementia Mission is one of the eight healthcare missions being tackled through the UK’s Life Sciences Vision and Drugs Strategy, in collaboration with industry, academia, the third sector and the NHS. It aims to improve translational capabilities in dementia and neurodegeneration by developing precision medicine tools that will help speed up clinical trials while improving accuracy and chance of success. Situated within a rich UK research ecosystem, the mission will build on existing UK and global dementia research initiatives and clinical research infrastructure.

Previously Megan held policy and strategy roles across government, working in NHSX on the NHS' digital strategy, in the Department for Business, Energy and Industrial Strategy, on energy innovation programmes, and in the Ministry of Defence, on science and technology exploitation practices. Megan joined the CSaP team briefly on secondment in 2018 to develop CSaP Cambridge Policy Forums to promote continued relationships between academics and policy makers and stimulate longer-term thinking and collaboration around policy issues.

Megan has a PhD in Physiology, Development and Neuroscience from the University of Cambridge, investigating the cellular and molecular mechanisms of neuronal patterning during brain development.